A detailed history of Riverbridge Partners LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Riverbridge Partners LLC holds 827,087 shares of TECH stock, worth $59.1 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
827,087
Previous 861,631 4.01%
Holding current value
$59.1 Million
Previous $60.7 Million 2.29%
% of portfolio
0.83%
Previous 0.77%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$62.12 - $84.15 $2.15 Million - $2.91 Million
-34,544 Reduced 4.01%
827,087 $59.3 Million
Q1 2024

Apr 26, 2024

SELL
$65.98 - $77.09 $367,376 - $429,237
-5,568 Reduced 0.64%
861,631 $60.7 Million
Q4 2023

Feb 15, 2024

SELL
$52.83 - $78.22 $795,514 - $1.18 Million
-15,058 Reduced 1.71%
867,199 $66.9 Million
Q4 2023

Jan 24, 2024

SELL
$52.83 - $78.22 $793,189 - $1.17 Million
-15,014 Reduced 2.08%
706,817 $54.5 Million
Q3 2023

Feb 15, 2024

BUY
$67.52 - $89.42 $11.8 Million - $15.7 Million
175,440 Added 24.82%
882,257 $60.1 Million
Q3 2023

Oct 16, 2023

SELL
$67.52 - $89.42 $12.2 Million - $16.2 Million
-180,949 Reduced 20.04%
721,831 $49.1 Million
Q2 2023

Jul 25, 2023

BUY
$73.76 - $85.98 $6.64 Million - $7.74 Million
90,066 Added 11.08%
902,780 $73.7 Million
Q1 2023

Apr 21, 2023

SELL
$71.62 - $86.62 $910,075 - $1.1 Million
-12,707 Reduced 1.54%
812,714 $60.3 Million
Q4 2022

Jan 11, 2023

BUY
$80.67 - $352.29 $49 Million - $214 Million
606,802 Added 277.56%
825,421 $68.4 Million
Q3 2022

Oct 26, 2022

BUY
$282.54 - $391.85 $11 Million - $15.2 Million
38,805 Added 21.58%
218,619 $62.1 Million
Q2 2022

Aug 29, 2022

SELL
$322.67 - $449.65 $14.6 Million - $20.4 Million
-45,296 Reduced 20.12%
179,814 $62.3 Million
Q2 2022

Jul 11, 2022

SELL
$322.67 - $449.65 $2.07 Million - $2.89 Million
-6,423 Reduced 2.77%
225,110 $78 Million
Q1 2022

Apr 20, 2022

SELL
$353.85 - $487.79 $1.01 Million - $1.39 Million
-2,856 Reduced 1.22%
231,533 $100 Million
Q4 2021

Jan 14, 2022

BUY
$456.15 - $525.06 $2.68 Million - $3.08 Million
5,872 Added 2.57%
234,389 $121 Million
Q3 2021

Oct 26, 2021

BUY
$444.87 - $538.88 $480,459 - $581,990
1,080 Added 0.47%
228,517 $111 Million
Q2 2021

Jul 26, 2021

BUY
$387.35 - $450.26 $4.7 Million - $5.46 Million
12,124 Added 5.63%
227,437 $102 Million
Q1 2021

Apr 21, 2021

SELL
$314.62 - $411.0 $68.8 Million - $89.9 Million
-218,674 Reduced 50.39%
215,313 $82.2 Million
Q4 2020

Jan 22, 2021

BUY
$246.9 - $321.87 $8.27 Million - $10.8 Million
33,485 Added 8.36%
433,987 $138 Million
Q3 2020

Oct 08, 2020

BUY
$232.22 - $282.96 $3.02 Million - $3.68 Million
13,003 Added 3.36%
400,502 $99.2 Million
Q2 2020

Jul 08, 2020

BUY
$185.43 - $279.56 $498,064 - $750,898
2,686 Added 0.7%
387,499 $102 Million
Q1 2020

Apr 13, 2020

SELL
$161.17 - $221.51 $490,762 - $674,497
-3,045 Reduced 0.79%
384,813 $73 Million
Q4 2019

Jan 14, 2020

SELL
$189.68 - $222.09 $1.7 Million - $1.99 Million
-8,981 Reduced 2.26%
387,858 $85.1 Million
Q3 2019

Oct 11, 2019

SELL
$183.56 - $216.72 $318,660 - $376,225
-1,736 Reduced 0.44%
396,839 $77.6 Million
Q2 2019

Jul 10, 2019

SELL
$188.72 - $215.43 $4.86 Million - $5.55 Million
-25,771 Reduced 6.07%
398,575 $83.1 Million
Q1 2019

Apr 04, 2019

SELL
$136.09 - $200.44 $6.98 Million - $10.3 Million
-51,260 Reduced 10.78%
424,346 $84.3 Million
Q4 2018

Jan 14, 2019

SELL
$132.75 - $203.8 $2.72 Million - $4.17 Million
-20,478 Reduced 4.13%
475,606 $68.8 Million
Q3 2018

Oct 03, 2018

SELL
$147.44 - $204.11 $2.92 Million - $4.04 Million
-19,779 Reduced 3.83%
496,084 $101 Million
Q2 2018

Jul 03, 2018

SELL
$144.9 - $165.58 $2.1 Million - $2.4 Million
-14,501 Reduced 2.73%
515,863 $76.3 Million
Q1 2018

Apr 03, 2018

BUY
$131.46 - $151.04 $348,631 - $400,558
2,652 Added 0.5%
530,364 $80.1 Million
Q4 2017

Jan 24, 2018

SELL
$121.17 - $134.75 $2.15 Million - $2.39 Million
-17,759 Reduced 3.26%
527,712 $68.4 Million
Q3 2017

Nov 01, 2017

BUY
$113.59 - $123.78 $62 Million - $67.5 Million
545,471
545,471 $65.9 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Riverbridge Partners LLC Portfolio

Follow Riverbridge Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverbridge Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverbridge Partners LLC with notifications on news.